Abducens Nerve Paralysis, Oculomotor Nerve Palsy, Trochlear Nerve Palsy
Conditions
Keywords
diplopia; ocular motor nerve palsy; acupuncture
Brief summary
This retrospective observational study is designed to assess the response to treatment with ocular acupuncture and its relative factors, in terms of diplopia status, ocular motility differences, and clinical features, in ocular motor nerve palsy patients. During this study, a retrospective data collection will be carried out using the information contained in the medical record of aimed patients, provided that the treatment with ocular acupuncture.
Interventions
OTHEROcular acupuncture
Patient's skin located in the extraocular muscles projection area is routinely disinfected. A diameter of 0.20 mm and length of 25 mm needle is inserted slowly. Piercing depth is about 20mm. The electropuncture apparatus is used, each group of electrodes are distinguished with different colors of wires to generate current stimulations of current 1.0\ 1.5 milliampere (mA), voltage 9 volt(V), frequency 1.5 hertz (Hz), and duration of 40 minutes.
Sponsors
First Affiliated Hospital of Harbin Medical University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age over 18 years old * Patient who received at lease 1 times of ocular acupuncture treatment * Patient who received full set of ophthalmology & neurology assessment pre- and post-treatment.
Exclusion criteria
* patient who combined with extraocular muscles diseases, eg.thyroid eye disease * patient who underwent periocular surgery * patient who combined with congenital ocular motor nerve palsy, eg. Brown syndrome. * patient who had untreated condition which may lead to ocular motor nerve palsy such as intracranial aneurysm and brain tumor.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical efficacy rate (Cure, Effective and Invalid) | Through study completion, an average of 1 month. | Clinical efficacy rate (Cure, Effective and Invalid) assessed by investigator's discretion. Efficacy rate is calculated as number of patients with Cure and effective proportional to number of all cases. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Diplopia angle | Through study completion, an average of 2 weeks. | Patient's diplopia angle obtained by retrospective chart review. |
| Eyeball movement distance | Through study completion, an average of 2 weeks. | Patient's eyeball movement distance obtained by retrospective chart review. |
| Distance between upper and lower eyelid. | Through study completion, an average of 2 weeks. | Patient's distance between upper and lower eyelid obtained by retrospective chart review. |
Contacts
Primary Contactlingyun zhou, PHD
Backup Contacttiejuan liu, PHD
Outcome results
None listed